SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?


To: Thomas M. who wrote (90070)3/6/2001 9:47:07 PM
From: Spekulatius  Read Replies (1) | Respond to of 132070
 
I do follow SEPR and consider the current stock price around 45$ attractive. SEPR has a stable of possible blockbuster in the pipeline,some of them are licensed to big pharma companies (Clarinex) but some of them will be marketed by SEPR. SEPR has ample cash (700M$) to develop its business plan and because of its pipeline a reasonable chance of becoming a very profitable fully integrated medium sized pharma company.